Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roderick Clifton-Bligh

Showing results (31-40 of 140) with videos related to

Pageof 14
Sort By:
Cancers|July 13, 2024
Medullary Thyroid Cancer: Molecular Drivers and Immune Cellular Milieu of the Tumour Microenvironment-Implications for Systemic TreatmentAlexander J Papachristos, Hazel Serrao-Brown, Anthony J Gill, et al.
Endocrine Reviews|February 20, 2024
The Immune Landscape of Pheochromocytoma and Paraganglioma: Current Advances and PerspectivesOndrej Uher, Katerina Hadrava Vanova, David Taïeb, et al.
Endocrinology, Diabetes & Metabolism Case Reports|October 12, 2018
A novel CASR mutation (p.Glu757Lys) causing autosomal dominant hypocalcaemia type 1Benjamin Kwan, Bernard Champion, Steven Boyages, et al.
Plos One|June 17, 2022
Metabolic changes in vitamin D receptor knockout miceSue Lynn Lau, Rebecca A Stokes, Beverly Ng, et al.
Pituitary|July 17, 2012
MGMT expression and pituitary tumours: relationship to tumour biologyAnn McCormack, Warren Kaplan, Anthony J Gill, et al.
Endocrinology, Diabetes & Metabolism Case Reports|November 22, 2019
Intractable hypercalcaemia during pregnancy and the postpartum secondary to pathogenic variants in CYP24A1Nirusha Arnold, Victor O'Toole, Tien Huynh, et al.
The Journal of Clinical Endocrinology and Metabolism|June 1, 2022
Selpercatinib Treatment of RET-Mutated Thyroid Cancers Is Associated With Gastrointestinal Adverse EffectsVenessa Tsang, Anthony Gill, Matti Gild, et al.
Clinical Endocrinology|February 5, 2020
Risk factors for development of diabetes mellitus (Type 3c) after partial pancreatectomy: A systematic reviewLinda Wu, Christopher B Nahm, Nigel B Jamieson, et al.
ANZ Journal of Surgery|October 1, 2024
Patience is key for the surgeon in the management of a large haemorrhagic phaeochromocytoma with cardiomyopathyJames A Pasch, Hazel Serrao-Brown, Daniel Nguyen, et al.
ANZ Journal of Surgery|October 30, 2013
Recurrent hyperaldosteronism after adrenalectomy: an indication for careful radiologic and histologic re-evaluationJustin S Gundara, Anthony J Gill, Anthony Glover, et al.
Pageof 14

Showing results (31-40 of 140) with videos related to

Sort By:
Pageof 14
Cancers|July 13, 2024
Medullary Thyroid Cancer: Molecular Drivers and Immune Cellular Milieu of the Tumour Microenvironment-Implications for Systemic TreatmentAlexander J Papachristos, Hazel Serrao-Brown, Anthony J Gill, et al.
Endocrine Reviews|February 20, 2024
The Immune Landscape of Pheochromocytoma and Paraganglioma: Current Advances and PerspectivesOndrej Uher, Katerina Hadrava Vanova, David Taïeb, et al.
Endocrinology, Diabetes & Metabolism Case Reports|October 12, 2018
A novel CASR mutation (p.Glu757Lys) causing autosomal dominant hypocalcaemia type 1Benjamin Kwan, Bernard Champion, Steven Boyages, et al.
Plos One|June 17, 2022
Metabolic changes in vitamin D receptor knockout miceSue Lynn Lau, Rebecca A Stokes, Beverly Ng, et al.
Pituitary|July 17, 2012
MGMT expression and pituitary tumours: relationship to tumour biologyAnn McCormack, Warren Kaplan, Anthony J Gill, et al.
Endocrinology, Diabetes & Metabolism Case Reports|November 22, 2019
Intractable hypercalcaemia during pregnancy and the postpartum secondary to pathogenic variants in CYP24A1Nirusha Arnold, Victor O'Toole, Tien Huynh, et al.
The Journal of Clinical Endocrinology and Metabolism|June 1, 2022
Selpercatinib Treatment of RET-Mutated Thyroid Cancers Is Associated With Gastrointestinal Adverse EffectsVenessa Tsang, Anthony Gill, Matti Gild, et al.
Clinical Endocrinology|February 5, 2020
Risk factors for development of diabetes mellitus (Type 3c) after partial pancreatectomy: A systematic reviewLinda Wu, Christopher B Nahm, Nigel B Jamieson, et al.
ANZ Journal of Surgery|October 1, 2024
Patience is key for the surgeon in the management of a large haemorrhagic phaeochromocytoma with cardiomyopathyJames A Pasch, Hazel Serrao-Brown, Daniel Nguyen, et al.
ANZ Journal of Surgery|October 30, 2013
Recurrent hyperaldosteronism after adrenalectomy: an indication for careful radiologic and histologic re-evaluationJustin S Gundara, Anthony J Gill, Anthony Glover, et al.
Pageof 14